GlassScriptPhysician profile
Frank N Grisafi
NPI 1487865994
$11,560.34
in general payments reported to CMS, 2019-2025
11 companies · $5,454 in 2025
The $5,454 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.07 · 2020: $138 · 2021: $4,762 · 2022: $1,050 · 2023: $70.00 · 2024: $26.94 · 2025: $5,454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,000 · Travel and Lodging: $1,813 · Food and Beverage: $738.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,000.00 |
| Travel and Lodging | $1,812.94 |
| Food and Beverage | $738.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intrinsic Therapeutics | $4,708.96 | 2025 | Barricaid Acd (Annular Closure Device) |
| Osseus Fusion Systems, LLC | $3,908.85 | 2020-2021 | |
| Globus Medical, INC. | $1,751.79 | 2022-2025 | Xlif, Excelsius Gps, Secure-C |
| Medtronic, INC. | $974.12 | 2021-2022 | |
| Alphatec Spine, INC | $52.97 | 2023 | |
| Innovation Technologies INC | $39.50 | 2022 | |
| Smith+Nephew, INC. | $34.98 | 2019 | |
| Averitas Pharma INC. | $26.94 | 2024 | Qutenza |
| Nevro Corp. | $24.09 | 2019 | |
| Orthofix Medical, INC. | $21.84 | 2020 | |
| Stryker Corporation | $16.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Grisafi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.